The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow.
Ingram
W
W
Lea
N C
NC
Cervera
J
J
Germing
U
U
Fenaux
P
P
Cassinat
B
B
Kiladjian
J J
JJ
Varkonyi
J
J
Antunovic
P
P
Westwood
N B
NB
Arno
M J
MJ
Mohamedali
A
A
Gaken
J
J
Kontou
T
T
Czepulkowski
B H
BH
Twine
N A
NA
Tamaska
J
J
Csomer
J
J
Benedek
S
S
Gattermann
N
N
Zipperer
E
E
Giagounidis
A
A
Garcia-Casado
Z
Z
Sanz
G
G
Mufti
G J
GJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001853:Bone Marrow / Q000473:pathology; D002455:Cell Division; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5; D005260:Female; D005819:Genetic Markers; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000145:classification / Q000235:genetics* / Q000473:pathology*; D017354:Point Mutation
D005819:Genetic Markers; C507924:JAK2 protein, human; D053614:Janus Kinase 2